Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolution of Proteinuria in Renal Transplant Patients Treated With Dapagliflozin for Nephroprotection. DAPAGREFFE

NCT06165601 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06165601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06165601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolution of Proteinuria in Renal Transplant Patients Treated With Dapagliflozin for Nephroprotection. DAPAGREFFE
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
January 4, 2024
Completion date
October 25, 2025
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases